Concomitant Dosimetry During Radionuclide Peptide Therapy with 177-Lu-DOTA-tate and 177-Lu-Lanreotide

被引:0
|
作者
Heute, D. R. [1 ]
Dobrozemsky, G. [1 ]
Traub, T. [1 ]
Warwitz, B. [1 ]
von Guggenberg, E. [1 ]
Gabriel, M. [1 ]
Virgolini, I. [1 ]
机构
[1] Med Univ Innsbruck, A-6020 Innsbruck, Austria
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S202 / S202
页数:1
相关论文
共 50 条
  • [1] Peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE
    Prado-Wohlwend, S.
    Bernal-Vergara, J. C.
    Utrera-Costero, A.
    Canon-Sanchez, J. R.
    Agudelo-Cifuentes, M.
    Bello-Arques, P.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2022, 41 (01): : 55 - 65
  • [2] Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC
    Wehrmann, Christiane
    Senftleben, Stefan
    Zachert, Carolin
    Mueller, Dirk
    Baum, Richard P.
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (03) : 406 - 416
  • [3] Dynamic Tumour Dosimetry Model for Peptide Radionuclide Therapy with 177Lu-DOTA-Octreotate
    Konijnenberg, M. W.
    Bernard, B. F.
    De Jong, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S101 - S101
  • [4] Kidney dosimetry in [ 177 Lu]Lu-DOTA-TATE therapy based on multiple small VOIs
    Kapidzic, Selma Curkic
    Gustafsson, Johan
    Larsson, Erik
    Jessen, Lovisa
    Gleisner, Katarina Sjogreen
    [J]. PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2024, 120
  • [5] 177Lu-DOTA-TATE in Peptide Receptor Radionuclide Therapy: first year experience in Turkey
    Kabasakal, L.
    Demirci, E.
    Ocak, M.
    Decristoforo, C.
    Papilla, C.
    Araman, A.
    Uslu, I.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S428 - S428
  • [6] Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
    Heribert Hänscheid
    Philipp E. Hartrampf
    Andreas Schirbel
    Andreas K. Buck
    Constantin Lapa
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2566 - 2572
  • [7] First comparative dosimetric results after peptide receptor radionuclide therapy (PRRT) using Lu-177 DOTA-NOC and Lu-177 DOTA-TATE
    Wehrmann, C.
    Senftleben, S.
    Baum, R. P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S373 - S373
  • [8] First comparative dosimetric results after peptide receptor radionuclide therapy (PRRT) using Lu-177 DOTA-NOC and Lu-177 DOTA-TATE
    Wehrmann, C.
    Senftleben, S.
    Baum, R. P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S179 - S179
  • [9] Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
    Haenscheid, Heribert
    Hartrampf, Philipp E.
    Schirbel, Andreas
    Buck, Andreas K.
    Lapa, Constantin
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (08) : 2566 - 2572
  • [10] Dosimetry in peptide receptor Radionuclide therapy (PRRT) using Lu-177 DOTA-TATE: Intra- and interpatient variability
    Wehrmann, C.
    Senftleben, S.
    Baum, R. P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S178 - S179